dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii has been researched along with Carcinoma, Anaplastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amselgruber, W; Humm, A; Schiller, CD; Schneider, MR; Schönenberger, H; Sinowatz, F; Spruss, T | 1 |
1 other study(ies) available for dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii and Carcinoma, Anaplastic
Article | Year |
---|---|
[1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloro-platinum(II): an endocrine-active platinum complex with a specific prostatic tumor-inhibiting activity.
Topics: Animals; Antineoplastic Agents; Carcinoma; Endocrine Glands; Male; Molecular Structure; Organ Size; Organoplatinum Compounds; Prostatic Neoplasms; Rats; Receptors, Androgen; Receptors, Estrogen; Receptors, Steroid; Recurrence; Testosterone | 1989 |